NTRK1 and medulloblastoma: ERBB4 is a tyrosine kinase receptor and is critical during cerebellum and medulloblastoma development (43), while SRC signaling controls important biological/oncogenic processes, including proliferation, apoptosis, cell adhesion and motility (44).